Manganese (Mn) is an environmental contaminant and its overexposure contributes to the pathophysiological processes of numerous disorders of the central nervous system in humans with mechanisms of action not completely understood. Activation of astrocytes and the subsequent release of neurotoxic factors have been implicated to contribute to neurodegeneration. Here, we assessed the molecular basis of the effects of Mn on modulation of matrix metalloproteinases-2 (MMP-2) and -9 (MMP-9) in rat astrocyte cultures. Primary cultures of rat astrocytes were exposed to different doses of MnCl 2 . Culture supernatants and cell lysates were used for the detection of MMP-2 and MMP-9 levels and mRNA expression, respectively. The exposure of astrocytes to MnCl 2 induced the levels and expression of MMP-9 in a dose-dependent manner. The addition of resveratrol (RSV) inhibited both levels and expression of MMP-9 in astrocytes, whereas N-acetylcysteine (NAC) and quercetin (QRC) were ineffective in inhibiting MMP-9. As a possible mechanism of Mn-induced MMP-9, we determined intracellular redox state in Mn-treated astrocytes by assessing superoxide dismutase (SOD) activity and intracellular reactive oxygen species (ROS) and found a significant increase of ROS and a decrease of SOD activity. RSV, NAC, and QRC restored the redox state. The study of the mitogen-activated protein kinase signaling pathway demonstrated that MMP-9 transcription is mainly regulated by extracellular-regulated protein kinases (ERK). Pretreatment with RSV significantly reduced ERK activation suggesting that its ability to counteract MMP-9 overexpression is due not only to a general redox balance phenomenon but also to the modulation of ERK signaling pathway.
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Toxic metals are individual metals and metal compounds that negatively affect health, even though many of these metals are necessary to support life at trace concentration. Manganese (Mn) is an essential mineral required for normal activity of many ubiquitous enzymatic reactions, including synthesis of amino acids, lipids, proteins, and carbohydrates. Despite the important requirement of Mn for cellular functions, a mounting body of evidence indicates that Mn is a common environmental contaminant and its overexposure contributes to the pathophysiological processes of numerous disorders of the central nervous system (CNS) in humans (Santamaria, 2008) .
Mn neurotoxicity results from an accumulation of metal in brain tissue. In contrast to the evidence for brain Mn influx, much less is known about the efflux of Mn, which could lead to Mn accumulation into brain and neurotoxicity (Crossgrove and Zheng, 2004) . The mechanisms by which Mn elicits damaging effects in disease states is not fully elucidated, although oxidative stress (OS) may be a primary route of action (Chen and Liao, 2002; Montes et al., 2001; Strokes et al., 2000) .
At high concentrations, reactive oxygen species (ROS) can be important mediators of damage to cellular structures such as nucleic acids, lipids, and proteins (Valko et al., 2005) . To counterbalance the excess of free radicals and to preserve intracellular redox homeostasis, organisms have developed a series of defense mechanisms that are able to increase the removal of radicals or block their formation. The antioxidant defense mechanisms against ROS include enzymes and low molecular weight antioxidants. One of the most effective intracellular enzymatic antioxidants is superoxide dismutase (SOD).
Increasing evidence suggests that Mn directly affects neurons by impairing energy metabolism and increasing the formation of ROS (HaMai and Bondy, 2004; Kitazawa et al., 2002; Milatovic et al., 2009; Zhang et al., 2003) . Specifically, Mn accumulates in mitochondria where inhibits oxidative toxicological sciences 135(1), 218-228 2013 doi:10.1093/toxsci/kft146 Advance Access publication June 28, 2013 phosphorylation and increases matrix calcium, ultimately driving the production of excess intracellular ROS (Gavin et al., 1990 (Gavin et al., , 1999 . However, although Mn can affect neurons directly, current research suggests that Mn may also indirectly enhance neurotoxicity through activation of astrocytes and microglia. A plethora of evidence suggests that astrocytes are the site of early dysfunction and damage in Mn neurotoxicity (Hazell, 2002) .
Astrocyte activation is manifested with an increase in nitric oxide, proinflammatory cytokine production (Barhoumi et al., 2004; Chang and Liu, 1999; Spranger et al., 1998) , and the release of neurotoxic factors such as matrix metalloproteinases (MMPs) (Rosenberg, 2009) .
MMPs are neutral, calcium-activated, Zn ++ -dependent endopeptidases known to degrade the components of the extracellular matrix (Visse and Nagase, 2003) . Overall, MMPs are largely absent from the normal CNS and their upregulation has been reported in several neurological disorders and after injury. Several studies have shown that MMP expression or secretion, particularly of MMP-2 and MMP-9 is increased during neurological disorders. Evidence is emerging of long-term effects of MMPs in neurodegenerative diseases, including damage to white matter in patients with multiple sclerosis, degradation of amyloid peptides in Alzheimer's disease, and apoptosis of dopaminergic neurons in Parkinson's disease (Rosenberg, 2009; Yong et al., 2007) .
The last few years have seen a growing interest in the effects of dietary antioxidants on human health. Many polyphenolic compounds from fruits and vegetables are known for their antioxidant properties and thus have been implicated as therapeutic agents (Pandey and Rizvi, 2009; Sun et al. 2008) . Their biological effects are ascribed mainly to their well-known properties as antioxidants and radical scavengers. However, some recent findings indicate that polyphenols have additional pleiotropic properties and modulate the activity of enzymes and transcription factors and influence gene expression (Prasad et al., 2010) . At the molecular level, polyphenols activate enzymes as AMP kinase (AMPK) and sirtuins (SIRT), and nuclear receptors such as the peroxisome proliferator-activated receptors (PPAR) and downregulate signal transduction pathways such as the mitogen-activated protein kinases (MAPKs), which play a crucial role in the transcription of various inflammatory molecules, such as MMP-9 (Das and Das, 2007; Van den Steen et al., 2002) .
On the basis of these observations, we have studied the effect of Mn on the activity and expression of MMP-2 and MMP-9 and demonstrated that in vitro treatment of astrocytes with Mn is able to upregulate MMP-9. To study mechanisms of Mn neurotoxicity, we measured intracellular levels of ROS and SOD activity and found that Mn induces OS in astrocytes. We also demonstrated the ability of resveratrol (RSV) to counteract the overexpression of MMP-9 with mechanisms related to the reduction of OS and the modulation of the extracellular-regulated protein kinases (ERK).
MATERiAl AND METHODS
Chemicals. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), penicillin and streptomycin were obtained from GIBCO (Paisley, Scotland). Gelatin, DNase 1, poly-l-lysine (PLL), trypsin, lipopolysaccharide (LPS), 1,10 phenanthroline (PA), Trypan Blue, 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT), RSV, Quercetin (QRC), and MnCl 2 were provided by Sigma (St. Louis, MO). 2′,7′-Dichlorofluorescein was from Calbiochem (La Jolla, CA). Bradford reagent, standard proteins, and R-250 Coomassie Brilliant Blue were purchased from Bio-Rad (Hercules, CA). PVDF membranes and enhanced chemiluminescence (ECL) analysis system were from Amersham Pharmacia Biotech (Buckinghamshire, UK). Anti-glial fibrillary acidic protein (GFAP) antibodies were purchased from Serotec (Oxford, UK). Antibodies against ERK-1/2, and α-actin were from Santa Cruz Biotechnology (Santa Cruz, CA). Primer pairs specific for MMP-2, MMP-9, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were from Sigma Genosys (Cambridgeshire, UK). RNeasy mini kit was from Qiagen (Valencia, CA). All the reagents for RT-PCR were purchased from Invitrogen (San Diego, CA).
Preparation of astrocyte cultures. Astrocytes were prepared from primary cell cultures of neocortical tissues from 1-day-old rats as described by Nakajima et al. (1989) . Briefly, brains were cleaned of meninges and blood vessels and the dissected neocortical tissues were minced by passage through a stainless steel mesh (40 mesh) and incubated with 0.25% trypsin and 0.01% DNase in DMEM for 10 min at 37°C. After addition of FBS, the dissociated cells were passed through a 100-mesh sieve and cell viability was assessed by Trypan Blue dye exclusion. Cells were plated in PLL-coated flasks (75 cm 2 ) at a density of 1.5 × 10 7 viable cells/flask in DMEM, 100 U/ml penicillin, 100 μg/ml streptomycin, 10% FBS, and maintained at 37°C in a 5% CO 2 incubator with a renewal of medium twice a week. After 7-10 days in culture, microglia and oligodendrocytes were separated from the astrocytes by mechanical dislodging and then the astrocytes were obtained by trypsinization (0.25% trypsin/0.02% EDTA) (McCarthy and De Vellis, 1980) . Astrocytes were purified by three repetitions of replating and trypsinization to deplete cultures of microglia and oligodendrocytes. The purity of the final cell culture was assessed by immunostaining for GFAP. More than 98% of the cells were GFAP positive in all the preparations.
Treatment of astrocytes.
One day after seeding at a density of 1 × 10 5 cells/ml in 96-well plates, astrocytes were washed twice with serum-free DMEM and treated with MnCl 2 at the final concentrations of 1, 10, and 50µM for 20 h. In other wells, cells were treated with 50µM of MnCl 2 in the presence of RSV (25 µg/ml), N-acetylcysteine (NAC) (500 µg/ml), or QRC (25 µg/ ml). Negative controls consisted of unstimulated and untreated astrocytes in serum-free DMEM; cells stimulated with a constant amount of LPS (10 µg/ ml) represented the positive control. The incubations were performed at 37°C in 100 µl of serum-free DMEM. At the end of the incubation period, the culture medium was collected and subjected to gelatin zymography. For the detection of SOD activity, cells were treated with MnCl 2 at the final concentrations of 1, 10, and 50µM for 3 h. In another set of experiments, astrocytes were pretreated for 1 h with RSV (25 µg/ml), NAC (500 µg/ml), or QRC (25 µg/ml), then treated for 3 h with MnCl 2 at the final concentration of 50µM. Unstimulated and untreated astrocytes or cells stimulated with H 2 O 2 (100µM) represented the negative and positive controls, respectively. After the incubation period, cells were lysed with Tris-HCl 10mM/NaCl 150mM/Triton X-100 0.5%/PMSF 1mM/leupeptin 20μM, pH 7.5, and lysates were at −80°C until use.
Cytotoxicity assay. Cytotoxicity of astrocytes after treatment with MnCl 2 was detected using MTT assay (Mosmann, 1983 ). This assay is based on the reduction of MTT, by the mitochondrial succinate dehydrogenase in viable cells, to a blue formazan product, which can be measured spectrophotometrically using a microplate reader (VersaMax, Molecular Devices). Briefly, triplicate samples of 1 × 10 5 cells, plated in 96-well plates in serum-free DMEM, were treated for 20 h with MnCl 2 at the final concentrations of 1, 10, and 50µM for 20 h. As a control, in other wells, cells were incubated in serum-free LATRONICO ET AL.
DMEM under the same conditions. After removal of the culture medium, cells were rinsed in PBS and incubated at 37°C, 5% CO 2 for 2 h with 0.5 mg/ml MTT. Reaction was stopped by removing the medium and the dye was dissolved in absolute ethanol. The difference between the absorbance of each sample at 560 and 690 nm was measured, and the value of the untreated sample was set at 100%.
Detection of gelatinases by zymography. Gelatinases in cell culture supernatants were detected by SDS-PAGE zymography according to the method of Heussen and Dowdle (1980) , as modified by Liuzzi et al. (2004) . Briefly, 50 µl of culture supernatant was supplemented with 30 µl of electrophoresis loading buffer containing SDS. Samples were then separated in a 7.5% polyacrylamide gel copolymerized with 0.1% (wt/vol) gelatin. Stacking gels contained 5.4% polyacrylamide. Electrophoresis was performed at 4°C for approximately 18 h at 80 V. After electrophoresis, gels were washed for 2 × 20 min in 2.5% (wt/vol) Triton X-100/10mM CaCl 2 in 50mM Tris-HCl, pH 7.4 (washing buffer) in order to remove SDS, then incubated for 24 h at 37°C in 1% (wt/vol) Triton X-100/50mM Tris-HCl/10mM CaCl 2 , pH 7.4 (developing buffer). For the development of enzyme activity, the gels were stained with Coomassie brilliant blue R-250 and destained in methanol/acetic acid/ H 2 O. Gelatinase activity was detected as a white band on a blue background and was quantified by computerized image analysis through monodimensional scanning densitometry using the Image Master 1D program (Pharmacia Biotech, Uppsala, Sweden). Gelatinase activity was expressed as optical density × mm 2 , representing the scanning area under the curves, which takes into account both brightness and width of the substrate lysis zone.
Reverse transcription-polymerase chain reaction. Total cellular RNA was extracted from astrocytes using the Qiagen RNeasy mini kit according to the manufacturer's instructions. The concentration and purity of the isolated RNA were determined by using the NanoDrop 1000 spectrophotometer (Thermo Scientific). Complementary DNA (cDNA) was synthesized from 500 ng of RNA by using the QuantiTect Reverse Transcription kit according to manufacturer's instructions. A total of 25 ng of reverse transcription products was used to amplify a 591-bp fragment using specific primers (sense: 5′-GTC ACT CCG CTG CGC TTT TCT CG-3′; antisense: 5′-GAC ACA TGG GGC ACC TTC TGA-3′) for the rat MMP-2 sequence and a 541-bp fragment using specific primers (sense: 5′-CGG AGC ACG GGG ACG GGT ATC-3′; antisense: 5′-AAG ACG AAG GGG AAG ACG CAC ATC-3′) for the rat MMP-9 sequence. Amplification of a 308-bp fragment of rat GAPDH (sense: 5′-TCC CTC AAG ATT GTC AGC AA-3′; antisense: 5′-AGA TCC ACA ACG GAT ACA TT-3′), a relatively invariant internal reference RNA, was performed in parallel. Twenty-five cycles of PCR were carried out, each one consisting of denaturation at 94°C, annealing at 59°C, and extension at 72°C in a thermal cycler (PTC-100 Programmable Thermac Controller, MJ Research, Inc., Walthan, MA). PCR products were visualized by ethidium bromide staining in 1.5% agarose gels. Gels were then processed for densitometric analysis as described for protein gels. Amplification of the target cDNAs was normalized to GAPDH expression.
Detection of MMP-2 and MMP-9 activity by in gel zymography. The ability of the different antioxidants used to inhibit MMP-2 and MMP-9 activity was determined by using an in vitro assay as already reported (Liuzzi et al., 2011) . Briefly, a serum sample containing high amounts of MMP-2 and MMP-9 was applied to gelatin zymography. After the electrophoretic run in SDS, gels were cut in slices and each slice was washed with Triton X-100 and incubated overnight in the incubation medium (50mM Tris; 1% Triton X-100; 10mM CaCl 2 ; 0.2% NaN3; pH 7.5) in the absence or in the presence of QRC (25 µg/ml), NAC (500 µg/ml), or RSV (25 µg/ml). PA at the concentration of 2mM was used as a positive control. Percentage of MMP-9 and MMP-2 inhibition, calculated in comparison to control (serum incubated in the absence of the antioxidants), were detected by computerized image analysis through monodimensional scanning densitometry after staining and destaining of the gels.
Measurement of intracellular free radicals.
For the detection of intracellular free radicals, astrocytes (in 6-well plates) were loaded with 5µM 2′,7′-dichlorofluorescein in phenol red-free DMEM at 37°C for 2 h, then wells were washed twice with DMEM and pretreated for 1 h with the corresponding antioxidants in phenol red-free DMEM. MnCl 2 at the final concentration of 50µM was then added to wells, and plates were incubated for 1 h. Unstimulated and untreated astrocytes or cells stimulated with H 2 O 2 (100µM) represented the negative and positive controls, respectively. Cells were lysed with Tris-HCl 10mM/NaCl 150mM/Triton X-100 0.5%/PMSF 1mM/DTT 1mM, pH 7, and centrifuged at 13,000 rpm. The fluorescent signal of oxidized 2′,7′-dichlorofluorescein was measured (excitation, 485 mm; emission, 520 nm) using a fluorometer (Perkin Elmer LS50). Results are expressed as percentages relative to control astrocytes arbitrarily set at 100%.
Measurement of SOD activity. SOD activity in cell lysates was determined spectrophotometrically from its ability to inhibit the autoxidation of epinephrine (Misra, 1985) . Stimulation of epinephrine autoxidation by traces of heavy metals present as contaminants in the reagents or by the other metals under investigation was prevented by adding 10 −4 M EDTA in the buffer to chelate these ions. Briefly, 2.9 ml of buffer consisting of NaHCO 3 /Na 2 CO 3 50mM/EDTA 0.1mM, pH 10.25 was placed in a 3-ml cuvette. The reaction was then initiated by adding 0.1 ml epinephrine 0.3mM, pH 2.0 in order to obtain a rate of increase in absorbance of 0.025 per minute at 480 nm. Another cuvette was then prepared in which 10 µg of cell lysate replaces an equal volume of buffer, and the rate was again recorded after adding epinephrine. One unit of SOD is defined as the amount of enzyme required to inhibit the rate of epinephrine autoxidation by 50%. The activity of SOD was assayed in triplicate.
Detection of ERK-1/2 by Western blot analysis. Confluent cultures of primary astrocytes plated in 6-well plates were pretreated for 1 h with RSV (25 µg/ml), NAC (500 µg/ml), or QRC (25 µg/ml), then treated for 1 h with MnCl 2 at the final concentration of 50µM. Unstimulated and untreated astrocytes represented the negative control. After the incubation period, cells were lysed with 20mM Tris-HCl/150mM NaCl/2.5mM Na pyrophosphate/1mM β-glycerophosphate/1% Triton X-100/1mM PMSF/20 μg/ml aprotinin/1mM EGTA/1mM Na fluoride/1mM Na 3 VO 4 , pH 7.5. Cell lysates were then homogenized and centrifuged at 13,000 rpm for 10 min at 4°C, and protein concentration was determined using the Bradford assay. Aliquotes of lysates corresponding to 40 µg of total proteins were precipitated with 1 ml cold acetone at −20°C for 1 h. After centrifugation, dry pellets were mixed with 12 µl of SDS buffer and electrophoresed in 10% SDS-PAGE gels. Proteins were then transferred to PVDF, and the membranes were blocked in PBS with 0.05% Tween 20/1% milk/1% BSA (blocking buffer) for 30 min at 4°C. The blots were then incubated overnight at 4°C with a monoclonal anti-p-ERK-1/2 antibody (1:500). After three washings, the membranes were probed with anti-mouse-HRP secondary antibodies (1:20,000). After 2-h incubation at room temperature, the blots were washed three times and ECL reagents were used for development. To assess the total amount of ERK, after exposure to autoradiographic films, membranes were stripped and incubated with an anti-rabbit antibody specific for nonphosphorylated ERK-1/2 (1:500), then probed with goat anti-rabbit-HRP secondary antibodies (1:20,000).
The quantification of levels of phosphorylation, obtained after densitometric scanning of blots and normalization to nonphosphorylated ERK-1/2, was expressed as percent compared with positive control (lysates from cells treated with Mn), indicated as 100%.
Statistical analysis. The data are expressed as mean values ± SD. Each experiment was repeated three times using batches of different culture preparations. Statistical analysis was carried out using one-way ANOVA followed by the post hoc Student-Newman-Keuls test (multiple comparison) to assess the statistical significance between treated and untreated groups through all experiments. A level of p < 0.05 was considered statistically significant.
RESulTS

Mn Increases Levels and mRNA Expression of MMP-9 in Astrocytes
The effect of MnCl 2 on levels of the 67 kDa MMP-2 and 92 kDa MMP-9 was detected by gelatin zymography in culture 220 supernatants from astrocytes. As shown in Figure 1A , only MMP-2 was detected in supernatants from unstimulated astrocytes (CTRL). Incubation of cells with different doses of MnCl 2 for 20 h induced a dose-dependent increase of MMP-9 levels as observed in LPS-activated astrocytes (positive control). The results from multiple experiments with different population of cultured astrocytes, calculated after scanning densitometry of gels, are shown in Figure 1B .
To determine whether the increase of MMP-9 levels in supernatants from astrocytes treated with MnCl 2 resulted from the induction of mRNA expression, RT-PCR analysis was performed. As shown in Figure 1C , the expression of MMP-9 was induced in Mn-treated astrocytes. Quantitation of results from independent experiments with different cell populations, after normalization with GAPDH, a housekeeping gene product used as an internal control, is reported in Figure 1D .
Mn Induces the Production of ROS in Astrocytes
To determine whether the effect of MnCl 2 on the increase of MMP-9 levels and expression may be related with the OS induced by this metal, intracellular ROS levels were assayed by the changes of the fluorescent signal after the addition of a nonfluorescent dye, 2′,7′-dichlorofluorescein. As shown in Figure 2 , the exposure to Mn enhanced fluorescent signal in Fig. 1 . Effect of treatment with MnCl 2 on MMP-2 and MMP-9 levels and mRNA expression in astrocytes. Primary astrocytes (1 × 10 5 cells/ml), incubated in serum-free DMEM, were treated with MnCl 2 at the indicated concentrations. Negative and positive controls were obtained from unstimulated and untreated astrocytes in serum-free DMEM (CTRL) and cells stimulated with LPS (10 µg/ml), respectively. (A and B) Culture supernatants were harvested after 20 h of incubation and subjected to gelatin zymography. Representative gel in (A) shows MMP-2 and MMP-9, as identified by their apparent molecular mass of 67 and 92 kDa, respectively, using prestained molecular weight markers (Bio-Rad). A band of apparent molecular mass of 72 kDa was also observed, corresponding to the proform of MMP-2. Histograms in (B) represent results, expressed as mean ± SD, after scanning densitometry and computerized analysis of gels from at least three independent experiments with different cell populations. Statistically significant dose-dependent induction of MMP-9 was observed when astrocytes were treated with MnCl 2 . (C and D) The isolated RNA samples were analyzed by RT-PCR, using the primer pairs specific for MMP-2, MMP-9, and GAPDH. The products were run on a 1.5% agarose gel containing ethidium bromide. The bands were visualized under UV. Representative results are shown in (C). Quantitation of the above experiment and two others after scanning densitometry is shown in (D). Results are expressed as mean ± SD. Statistically significant increase in comparison to CTRL is indicated by asterisks (one-way ANOVA followed by Student-Newman-Keuls; *p < 0.05 and **p < 0.001).
astrocytes in comparison to control (CTRL). However, the production of ROS in Mn-treated astrocytes was lower in comparison with that of positive control, represented by H 2 O 2 -treated astrocytes. The enhancement of fluorescence induced by both Mn and H 2 O 2 was reduced by the antioxidants RSV, QRC, and NAC.
MnCl 2 Decreases SOD Activity in Lysates from Astrocytes
Because the presence of OS might be due not only to an increased production of ROS but also to an altered function of the endogenous antioxidant defense, we detected SOD activity in lysates from astrocytes treated with increasing concentrations of MnCl 2 for 3 h. As shown in Figure 3 , a statistically significant decrease of SOD activity was observed in lysates from astrocytes treated with 50µM of Mn.
As reported in Figure 4 , the treatment of astrocytes with the antioxidants RSV (A), NAC (B), or QRC (C) induced a statistically significant increase of SOD activity in comparison to control. In addition, all the antioxidants used were able to counteract the decrease of SOD activity in both H 2 O 2 -and Mn-treated astrocytes.
RSV Counteracts the Effect of MnCl 2 on MMP-9 Levels and Expression
In order to ascertain whether the effect exerted by Mn on MMP-9 levels and expression might depend from the OS, studies were then performed to examine whether the antioxidants RSV, QRC, and NAC were also able to counteract the increase of MMP-9 levels and mRNA expression in Mn-treated astrocytes. As shown in Figures 5A and 5B, a statistical significant decrease of MMP-9 levels and expression was observed in astrocytes that were simultaneously treated with 50µM of MnCl 2 and 25 µg/ml of RSV. Only a 20% inhibition of MMP-9 levels was observed by NAC and QRC which, however, were ineffective in inhibiting MMP-9 mRNA expression. No inhibitory effects of the studied antioxidants were detected on MMP-2 levels and expression.
The microscopical observation of cells ( Figure 6 ) and the cytotoxicity assay (data not shown) indicated that MnCl 2 and RSV, at the used concentrations, did not exert any proliferative or cytotoxic effect on astrocytes. Indeed, no change in morphology and cell number was observed, suggesting that the changes in the expression and levels of MMP-9 were due to the direct effect of MnCl 2 and RSV on the enzyme production.
ERK-1/2 MAPK Mediates Mn-induced MMP-9 Upregulation
To further elucidate the molecular mechanisms of Mn to affect MMP-9 expression, we initially used an indirect method in which astrocytes were pretreated with an ERK inhibitor (PD98059), a p38 inhibitor (SB203580), or a JNK inhibitor (SP600125) before the challenge with MnCl 2 . As shown in Figure 7A , the analysis by gelatin zymography showed that MMP-9 levels were undetectable in control supernatants and were induced by exposure to MnCl 2 . Pretreatment of astrocytes with PD98059 induced a statistically significant decrease of MMP-9 levels, whereas pretreatment with both SB203580 and SP600125 did not affect MMP-9 levels in Mn-treated astrocytes. This result indicates that Mn activates the transcription of MMP-9 gene mainly through the ERK-1/2 pathway. Therefore, we investigated the mechanisms of signal transduction through the determination of the state of activation of ERK-1/2 after exposure to MnCl 2 following pretreatment with the inhibitors Fig. 2 . Effect of MnCl 2 on the production of ROS in astrocytes. The presence of ROS was assayed by measuring the changes of the fluorescent signal of 2′,7′-dichlorofluorescein as reported in the Materials and Methods section. Astrocytes were exposed to medium alone (CTRL) or to 50µM MnCl 2 in the presence or in the absence of 25 µg/ml RSV, 25 µg/ml QRC, or 500 µg/ml NAC. H 2 O 2 at the final concentration of 100µM was used as positive control. The resulting fluorescent signal (express as mean fluorescence intensity [MFI]/µg protein) was measured by fluorometer. Data are means ± SD of three separate experiments with different cell populations (one-way ANOVA followed by Student-Newman-Keuls; *p < 0.05 and **p < 0.001). Fig. 3 . SOD activity in rat astrocytes treated with MnCl 2 . The activity of SOD was determined using a spectrophotometric assay in 10 μg of cell lysate proteins from primary astrocytes (1 × 10 5 cells/ml) untreated (CTRL) or treated for 3 h with different concentrations of MnCl 2 . Values represent the mean ± SD (three replicates) of three independent experiments with different cell populations. Statistically significant decrease in comparison to CTRL is indicated by asterisk (one-way ANOVA followed by Student-Newman-Keuls; *p < 0.05).
SB203580, SP600125, and PD98059. As shown in Figure 7B , the treatment with Mn alone induced a significant increase in the level of phosphorylation of ERK-1/2 that was counteracted by the pretreatment with PD98059. By contrast, pretreatment with SB203580 and SP600125 had no effect on the activation of ERK-1/2 in Mn-induced astrocytes (Fig. 7B) . Pretreatment of Mn-exposed astrocytes with QRC, NAC, or RSV (Fig. 7C) showed that only RSV significantly reduced phosphorylated ERK (p-ERK) 1/2 levels and this reduction was comparable to that observed when astrocytes were pretreated in the same experimental conditions with the ERK inhibitor PD98059.
DiSCuSSiON
Chronic intoxication by Mn occurs mostly occupationally or in populations living near ferroalloy plants, with abnormal liver function or receiving total parenteral nutrition (Bowler et al., 2007; Lucchini et al., 1999; Takagi et al., 2001) . Increased exposure to Mn leads to accumulation of this metal in the brain and neurological manifestations primarily derived from perturbation of normal basal ganglia function.
Recent reports indicate that Mn is involved in the pathophysiological processes of numerous disorders of CNS such as Parkinson's, Alzheimer disease, and Amyotrophic Lateral Sclerosis (Bowman et al., 2011) . Although the mechanisms of Mn neurotoxicity are not well known, it is clearly established that this metal accumulates in astrocytes because of the presence of high-capacity transporters in these cells (Aschner et al., 1999) . Such preferential accumulation suggests that astrocytes may be more vulnerable to Mn toxicity than other neural cells. Consistent with this possibility, animal models of Mn toxicity have shown astrocytic pathological alterations identified as Alzheimer type II astrocytosis (Hazell et al., 2006; Olanow et al., 1996) . In vivo studies have also demonstrated that pallidal regions of Mn-treated mice coincided with increased number of reactive astrocytes expressing inducible nitric oxide synthase in the same brain areas (Liu et al., 2006) . In culture, Mn-treated astrocytes increase their ability to indirectly induce and/or exacerbate neuronal dysfunction, as evidenced by the increased expression of proinflammatory mediators.
In this study, we demonstrated that Mn is able to induce levels and mRNA expression of gelatinases A (MMP-2) and B (MMP-9), which represent crucial factors in the pathogenesis of numerous diseases of the CNS (Rosenberg, 2009) . Mechanisms by which Mn induce MMP-9 expression are not clear, but several experimental evidences have clearly indicated that free radicals, in particular highly ROS and reactive nitrogen species, may induce MMP production (Nelson and Melendez, 2004) . It is noteworthy that OS has been implicated as a contributing mechanism by which Mn can be toxic to cells (Milatovic et al., 2009) .
To study whether Mn could be able to dysregulate the intracellular brain homeostasis in our experimental system, we Fig. 4 . Effect of RSV, NAC, and QRC on SOD activity in Mn-treated astrocytes. The activity of SOD was measured by using a spectrophotometric enzymatic assay in 10 μg of cell lysate proteins from primary astrocytes (1 × 10 5 cells/ml) pretreated for 1 h with RSV (25 µg/ml), NAC (500 µg/ml), or QRC (25 µg/ml), then exposed for 3 h to MnCl 2 (50µM) or H 2 O 2 (100µM). Values represent the mean ± SD (three replicates) of three separate experiments with different cell populations. All the antioxidants used were able to increase significantly the activity of SOD in comparison to untreated astrocytes (CTRL) and to both H 2 O 2 -and Mn-treated astrocytes (Student's t-test; *p < 0.05 and **p < 0.001).
studied the effects of Mn on ROS formation and SOD activity and found increased levels of intracellular ROS and decreased SOD activity in Mn-treated astrocytes. In the nervous system, as in other organs, SOD represents the first line of endogenous defense against ROS. Indeed, SOD is a key antioxidant involved in superoxide detoxification in normal cellular metabolism and after cell injury. Therefore, the decreased activity of this enzyme may be responsible for the imbalance between pro-oxidants and antioxidants leading to the increase of free radicals, which in turn stimulate the production of toxic factors. In such a situation, the use of exogenous antioxidants may help to counteract the excess of ROS production due to an inefficient functioning of the endogenous antioxidant systems.
Among antioxidants, dietary polyphenols have been widely studied for their strong antioxidant capacities and their recognized anti-inflammatory, immunomodulatory, antiviral, and neuroprotective properties, which might be beneficial for the treatment of different diseases (Fonseca-Kelly et al., 2012; Sun et al., 2010) . In this study, we compared the effect of two different polyphenols, the flavonoid QRC and the nonflavonoid RSV, and the thiol containing antioxidant NAC in Mn-treated astrocytes. The results obtained strongly indicated that Mn induces OS and that all the used antioxidants, by reducing levels of ROS and increasing SOD activity in Mn-treated astrocytes, were able to restore the intracellular redox balance with the same efficiency. Surprisingly, the used antioxidants did not 5 cells/ ml), incubated in serum-free DMEM, were treated with 50μM of MnCl 2 in presence or in absence of RSV (25 µg/ml), QRC (25 µg/ml), or NAC (500 µg/ml). Negative control (CTRL) was obtained from untreated astrocytes in serum-free DMEM. After 20 h of incubation, culture supernatants were harvested and cells were subjected to total RNA extraction. (A) Representative gel shows MMP-2 and MMP-9 levels in culture supernatants, as detected by gelatin zymography. (B) The isolated RNA samples were analyzed by RT-PCR, using the primer pairs specific for MMP-2, MMP-9, and GAPDH. The products were run on a 1.5% agarose gel containing ethidium bromide. The bands were visualized under UV light. Histograms in (A) and (B) represent results, expressed as mean ± SD, after scanning densitometry and computerized analysis of gels from at least three independent experiments with different cell populations. Asterisks represent values statistically different from negative control, which was set at 100% (one-way ANOVA followed by Student-Newman-Keuls post hoc test; *p < 0.05 and **p < 0.001).
exhibit the same efficiency in downregulating MMP-9. Indeed, in our experiments, only RSV was able to significantly counteract the increase of MMP-9 expression in Mn-treated astrocytes. Therefore, the partial reduction of MMP-9 levels by NAC and QRC could be due to a direct effect of these antioxidants on the activity of this enzyme as already demonstrated (Liuzzi et al., 2011) . This result suggests that the inhibition of MMP-9 by RSV is not only the effect of a general redox balance phenomenon but also probably due to a more specific mechanism.
Accumulating evidence suggests that RSV may exert a protective effect in the CNS under pathological conditions and that the intake of RSV is associated with a reduced risk of cardiovascular diseases, cancer, and diabetes (Ates et al., 2007; Bhat and Pezzuto, 2002; Das and Maulik, 2006; Karuppagounder et al., 2009) . Although the mechanisms by which RSV exerts such a wide range of beneficial effects on these diseases have not yet been clearly elucidated, a number of studies have reported that RSV has anticarcinogenic, anti-inflammatory, and estrogenic activities and allows free-radical scavenging (de la Lastra and Villegas, 2005; Shakibaei et al., 2009) . The action of RSV is expressed through the upregulation of enzymes and transcription factors implicated in phenomena that regulate cell survival, aging, apoptosis, and stress resistance, such as SIRT and AMPK, and nuclear receptors such as the PPAR, and the inhibition of proinflammatory transcription factors and pathways such as MAPK and mTOR (Prasad et al., 2010; Vingtdeux et al., 2010) . Therefore, we can hypothesize that the inhibition of MMP-9 by RSV in Mn-treated astrocytes occurs through its ability to downregulate the activation of the factors involved in the transcription of MMP-9 gene. Experimental evidences have indicated that Mn can activate different signaling pathways related to cell response during oxidative/calcium stress (Chen et al., 2006; Cordova et al., 2012) . Among these, different reports have shown that a primary route of action of Mn is through the activation of MAPKs (Crittenden and Filipov, 2011) , which in turn, have been demonstrated to be the main components of the induction pathway of the MMP-9 gene (Van den Steen et al., 2002) . In particular, MMP-9 expression has Histograms represent the mean levels ± SD of MMP-9 calculated after scanning densitometry and computerized analysis of gelatin-copolymerized gels. (B and C) Detection of p-ERK-1/2 and total ERK-1/2 by Western blotting analysis of cell lysates from astrocytes treated for 1 h with 50µM MnCl 2 after pretreatment with SB203580, SP600125, and PD98059 (B) or with the antioxidants QRC (25 µg/ml), NAC (500 µg/ml), or RSV (25 µg/ml). Histograms show results, after densitometric scanning of autoradiographic films, normalized as a ratio of phosphorylated to total ERK protein. Data represent means ± SD of three independent experiments. Asterisks represent values statistically different from positive control (MnCl 2 -treated astrocytes), which was set at 100% (one-way ANOVA followed by Student-Newman-Keuls post hoc test; *p < 0.05).
been demonstrated to be driven by three different MAPK signaling cascades and to be mediated mainly through activation of the transcription factors NF-kB and AP-1, via the Janus-protein tyrosine kinase (JNK)/SAPK, the ERK-1/2, or the p38 MAPK pathways.
For this reason, in order to further elucidate mechanisms by which Mn induce MMP-9 expression and its inhibition by RSV, we analyzed which of the three pathways of MAPK was implicated in the induction of MMP-9 by Mn. By using MAPK inhibitors and the zymographic analysis, we ascertained that Mn induces MMP-9 in astrocytes via the pathway of ERK-1/2. Increased levels of p-ERK in Mn-exposed astrocytes further confirmed this result. The pretreatment of astrocytes with RSV, NAC, or QRC showed that only RSV was able to reduce protein levels of p-ERK.
Taken together, results of this study indicate that Mn can strongly potentiate the inflammatory pathways in astrocytes by the release of MMP-9 and the reduction of SOD activity. This may provide new insights into metal-induced toxicity in human neurodegeneration.
The ability of RSV to counteract the overexpression of MMP-9 is related not only to its scavenging activity, but rather to a specific effect related to the modulation of ERK signaling pathway.
In conclusion, the effect of RSV on MMP-9 production and SOD activity in Mn-treated astrocytes suggests that a diet supplementation with this antioxidant compound may represent a suitable treatment regimen in combination with the conventional therapies for the treatment of neuroinflammatory diseases in which toxic metals, ROS, and MMPs may play a critical role. 
